The Technical Field "アミノ酸" had 1,419 patent application filings in the most recent period (2022-01-01 to 2022-07-31). This is a significantly decreased of -988 filings (-41.0%) over 2,407 they had in the same period of the previous year (2021-01-01 to 2021-07-31). This report also includes technical terms related to " アミノ酸類 " in the search set.
The highest number of filings in 2017 with 4,903 cases, and their lowest number in 2022 with 1,589 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 18,990 cases in total) is 3,165, and the median is 4,009. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 3,165 patents |
Std Dev | 1,720 |
COV | 0.5 |
The number of filings has been decreasing for the last 3 years (2020 to 2023).
Year | Cases | YOY |
---|---|---|
2022 year | 1,589 cases | -60.9 % |
2021 year | 4,061 cases | +2.63 % |
2020 year | 3,957 cases | -12.36 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for アミノ酸 for the period of the last 10 years (2014-01-01 to 2024-03-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of アミノ酸, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of アミノ酸 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
This patent analysis report was created for a patent search set of 37,217 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as アミノ酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 40 cases, followed by リジェネロン・ファーマシューティカルズ・インコーポレイテッド with 17 cases.
Name | Cases |
---|---|
花王株式会社 | 40 cases |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 17 cases |
ノバルティスアーゲー | 13 cases |
中外製薬株式会社 | 12 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 12 cases |
味の素株式会社 | 9 cases |
国立研究開発法人産業技術総合研究所 | 8 cases |
ジェネンテックインコーポレイテッド | 6 cases |
武田薬品工業株式会社 | 3 cases |
エフホフマン-ラロシュアーゲー | 1 cases |
Comparing the number of applications of each company, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last for the target period (2014 to 2024) with 506 cases, followed by リジェネロン・ファーマシューティカルズ・インコーポレイテッド with 462 cases.
Name | Cases |
---|---|
ジェネンテックインコーポレイテッド | 506 cases |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 462 cases |
ノバルティスアーゲー | 390 cases |
味の素株式会社 | 350 cases |
花王株式会社 | 288 cases |
エフホフマン-ラロシュアーゲー | 262 cases |
中外製薬株式会社 | 251 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 238 cases |
国立研究開発法人産業技術総合研究所 | 157 cases |
武田薬品工業株式会社 | 99 cases |
国立研究開発法人科学技術振興機構 | 22 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as アミノ酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 40 cases, followed by ノバルティスアーゲー with 13 cases.
Name | Cases |
---|---|
花王株式会社 | 40 cases |
ノバルティスアーゲー | 13 cases |
味の素株式会社 | 9 cases |
国立研究開発法人産業技術総合研究所 | 8 cases |
ジェネンテックインコーポレイテッド | 6 cases |
武田薬品工業株式会社 | 3 cases |
Among the top coapplicants, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last for the target period (2014 to 2024) with 506 cases, followed by ノバルティスアーゲー with 390 cases.
Name | Cases |
---|---|
ジェネンテックインコーポレイテッド | 506 cases |
ノバルティスアーゲー | 390 cases |
味の素株式会社 | 350 cases |
花王株式会社 | 288 cases |
国立研究開発法人産業技術総合研究所 | 157 cases |
武田薬品工業株式会社 | 99 cases |
国立研究開発法人科学技術振興機構 | 22 cases |
Below is a ranking of the number of JP patent applications by アミノ酸’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by アミノ酸’s top 7 coapplicants over the last 20 years.
アミノ酸 filed 350 joint applications with 味の素株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 129 cases in total) is 21.5, and the median is 11.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 81 cases, and their lowest number in 2022 with 5 cases.
Index | Value |
---|---|
Average | 21.5 patents |
Std Dev | 19.8 |
COV | 0.9 |
Year | Cases | YOY |
---|---|---|
2022 year | 5 cases | -28.57 % |
2021 year | 7 cases | -53.3 % |
2020 year | 15 cases | -68.8 % |
アミノ酸 filed 506 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 158 cases in total) is 26.3, and the median is 32.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 102 cases, and their lowest number in 2022 with 6 cases.
Index | Value |
---|---|
Average | 26.3 patents |
Std Dev | 17.7 |
COV | 0.7 |
Year | Cases | YOY |
---|---|---|
2022 year | 6 cases | -81.8 % |
2021 year | 33 cases | +6.45 % |
2020 year | 31 cases | -18.42 % |
アミノ酸 filed 288 joint applications with 花王株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 154 cases in total) is 25.7, and the median is 28.5. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been increasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 44 cases, and their lowest number in 2019 with 22 cases.
Index | Value |
---|---|
Average | 25.7 patents |
Std Dev | 11.2 |
COV | 0.4 |
Year | Cases | YOY |
---|---|---|
2022 year | 37 cases | +5.71 % |
2021 year | 35 cases | +25.00 % |
2020 year | 28 cases | +27.27 % |
アミノ酸 filed 99 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 57 cases in total) is 9.5, and the median is 11.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2021 with 18 cases, and their lowest number in 2022 with 3 cases.
Index | Value |
---|---|
Average | 9.5 patents |
Std Dev | 6.1 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 3 cases | -83.3 % |
2021 year | 18 cases | +50.0 % |
2020 year | 12 cases | -7.69 % |
アミノ酸 filed 157 joint applications with 国立研究開発法人産業技術総合研究所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 71 cases in total) is 11.8, and the median is 12.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 25 cases, and their lowest number in 2022 with 8 cases.
Index | Value |
---|---|
Average | 11.8 patents |
Std Dev | 6.9 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 8 cases | -42.9 % |
2021 year | 14 cases | +40.0 % |
2020 year | 10 cases | -44.4 % |
The following shows JP patents held by アミノ酸 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and アミノ酸’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which アミノ酸 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 8 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.4 times. The most recently Invalidation Trial patent is 特許4171216 "含硫化合物と微量金属元素を含む輸液製剤" (Invalidation Trial day 2023-05-30) , next is 特許7016341 "PD-1軸結合アンタゴニスト及びTIGIT阻害剤を使用するがんの治療方法" (Invalidation Trial day 2023-03-27) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許4171216 | 含硫化合物と微量金属元素を含む輸液製剤 | 2023-05-30 |
2 | 特許7016341 | PD-1軸結合アンタゴニスト及びTIGIT阻害剤を使用するがんの治療方法 | 2023-03-27 |
3 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
4 | 特許6914336 | 進行したHER2発現がんの治療 | 2022-11-15 |
5 | 特許6278598 | 細胞傷害誘導治療剤 | 2022-03-31 |
6 | 特許6773929 | 細胞傷害誘導治療剤 | 2022-03-31 |
7 | 特許6692856 | RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物 | 2022-02-25 |
8 | 特許6738314 | BCMAおよびCD3に対する結合分子 | 2021-07-02 |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 8 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.1. The most invalidation trial patent is 特許5906333 "プロタンパク質コンベルターゼスブチリシンケクシン9型(PCSK9)に対する抗原結合タンパク質" (2 times) , and the next most invalidation trial patent is 特許6522072 "イズロン酸−2−スルファターゼのCNS送達のための方法および組成物" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許5906333 | プロタンパク質コンベルターゼスブチリシンケクシン9型(PCSK9)に対する抗原結合タンパク質 | 2 times |
2 | 特許6522072 | イズロン酸−2−スルファターゼのCNS送達のための方法および組成物 | 1 times |
3 | 特許7016341 | PD-1軸結合アンタゴニスト及びTIGIT阻害剤を使用するがんの治療方法 | 1 times |
4 | 特許6896700 | ワクチン組成物 | 1 times |
5 | 特許6074462 | 抗−TNFα抗体の投与方法 | 1 times |
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 62 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7302754 "ガスバリア性塗料組成物及びガスバリア性積層体" (Opposition day 2023-12-28) , next is 特許7275044 "慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品" (Opposition day 2023-11-17) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7302754 | ガスバリア性塗料組成物及びガスバリア性積層体 | 2023-12-28 |
2 | 特許7275044 | 慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品 | 2023-11-17 |
3 | 特許7270912 | アドレノメデュリン濃度変動による予後予測の情報提供方法及びその試薬 | 2023-11-13 |
4 | 特許7272806 | 皮膚化粧料 | 2023-10-31 |
5 | 特許7266904 | 発泡性清酒の製造方法 | 2023-10-30 |
6 | 特許7253887 | ビールテイスト飲料およびその製造方法 | 2023-10-05 |
7 | 特許7257001 | ポリオレフィン樹脂フィルム | 2023-10-02 |
8 | 特許7240675 | オトフェルリンを発現させるための組成物および方法 | 2023-09-19 |
9 | 特許7241156 | ビールテイスト飲料 | 2023-09-19 |
10 | 特許7237544 | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 | 2023-09-11 |
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 190 patents Protest from third parties. The average number of Protest is 1.4 times. The most recently Protest patent is 特開2022-115557 "鶏卵の品質を予測する方法" (Protest day 2024-03-26) , next is 特表2021-527040 "カンプトテシンコンジュゲート" (Protest day 2024-03-25) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特開2022-115557 | 鶏卵の品質を予測する方法 | 2024-03-26 |
2 | 特表2021-527040 | カンプトテシンコンジュゲート | 2024-03-25 |
3 | 特開2021-065164 | 乳児用栄養組成物 | 2024-03-21 |
4 | 特開2022-049999 | 洗浄料 | 2024-03-15 |
5 | 特表2023-506785 | 炭酸アルコール飲料 | 2024-03-15 |
6 | 特開2021-143156 | シャンプー組成物 | 2024-03-15 |
7 | 特表2022-551149 | パーソナルケア組成物の防腐剤濃度の最適化 | 2024-03-12 |
8 | 特表2023-519172 | 胃腸微生物代謝経路及び代謝物を調節する方法 | 2024-03-08 |
9 | 特開2021-129533 | 経口用組成物 | 2024-02-26 |
10 | 特開2022-074430 | 非酸性アミノ酸含有酵母調味料 | 2024-02-22 |
11 | 特開2023-171429 | 新規リパーゼ及びその用途 | 2024-02-21 |
12 | 特開2021-180614 | 栄養補助組成物及びその製造方法、栄養補助組成物の不快臭の抑制方法、並びに栄養補助組成物の不快臭抑制用組成物 | 2024-02-20 |
13 | 特開2023-052694 | 悪臭調節化合物の同定方法 | 2024-02-17 |
14 | 特開2022-187349 | 含硫化合物臭の抑制剤の探索方法 | 2024-02-17 |
15 | 特開2023-174085 | アンモニア臭の抑制剤の探索方法 | 2024-02-17 |
16 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-02-16 |
17 | 特表2022-513924 | 最適な分子量および粘度の熱可塑性ポリマーを含浸させた繊維材料ならびにその製造方法 | 2024-02-13 |
18 | 特開2020-109085 | ニコチン酸アミドを含有する油中水型乳化組成物 | 2024-02-06 |
19 | 特開2023-165949 | 皮膚外用剤 | 2024-01-30 |
20 | 特表2022-504702 | 緩衝塩及びアミノ酸を含有する粉末、そのような粉末の栄養製品への再構成、並びにそのような栄養製品を使用する方法 | 2024-01-30 |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 355 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.4. The most protest patent is 特許6764792 "ケラチン処理調合物及び方法" (6 times) , and the next most protest patent is 特開2023-071594 "口腔用組成物" (6 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6764792 | ケラチン処理調合物及び方法 | 6 times |
2 | 特開2023-071594 | 口腔用組成物 | 6 times |
3 | 特許7455408 | 高温で保存される清酒の製造方法及び保存方法 | 6 times |
4 | 特許6529907 | マイコプラズマ・ニューモニエの免疫学的検出法およびキット | 6 times |
5 | 特許6831639 | 水中油型乳化組成物 | 6 times |
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 734 patents Inspection from third parties. The average number of Inspection is 1.5 times. The most recently Inspection patent is 特表2020-506708 "CO2および他のC1基質の、ビーガン栄養素、肥料、バイオスティミュラント、および土壌炭素隔離の加速のためのシステムへの微生物変換" (Inspection day 2024-03-19) , next is 特表2022-552052 "抗VEGFタンパク質組成物及びその製造方法" (Inspection day 2024-03-19) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特表2020-506708 | CO2および他のC1基質の、ビーガン栄養素、肥料、バイオスティミュラント、および土壌炭素隔離の加速のためのシステムへの微生物変換 | 2024-03-19 |
2 | 特表2022-552052 | 抗VEGFタンパク質組成物及びその製造方法 | 2024-03-19 |
3 | 特表2022-551149 | パーソナルケア組成物の防腐剤濃度の最適化 | 2024-03-19 |
4 | 特開2022-124931 | シワ改善剤、およびコラーゲン産生促進剤 | 2024-03-18 |
5 | 特開2022-187349 | 含硫化合物臭の抑制剤の探索方法 | 2024-03-14 |
6 | 特開2023-174085 | アンモニア臭の抑制剤の探索方法 | 2024-03-14 |
7 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-03-11 |
8 | 特許7458678 | タンパク質同定のためのデコーディングアプローチ方法 | 2024-03-07 |
9 | 特表2021-519790 | エレヌマブ組成物及びその使用 | 2024-03-06 |
10 | 特開2021-180614 | 栄養補助組成物及びその製造方法、栄養補助組成物の不快臭の抑制方法、並びに栄養補助組成物の不快臭抑制用組成物 | 2024-03-04 |
11 | 特開2023-165949 | 皮膚外用剤 | 2024-02-27 |
12 | 特表2022-513924 | 最適な分子量および粘度の熱可塑性ポリマーを含浸させた繊維材料ならびにその製造方法 | 2024-02-27 |
13 | 特開2022-081543 | 抗TREM2抗体及びその使用方法 | 2024-02-27 |
14 | 特表2021-531276 | 完全ヒトグリコシル化ヒトα−L−イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 | 2024-02-22 |
15 | 特表2021-531038 | ストレス顆粒集合を調節するためのシステム及び方法 | 2024-02-20 |
16 | 特開2023-168651 | 銅-亜鉛合金電気めっき液、銅-亜鉛合金バンプの形成方法、ナノポーラス銅バンプの形成方法、銅-亜鉛合金バンプ付き基材及びナノポーラス銅バンプ付き基材 | 2024-02-20 |
17 | 特表2021-516222 | 副甲状腺ホルモンポリペプチドコンジュゲートおよびその使用方法 | 2024-02-20 |
18 | 特表2019-531394 | 反りを制限するための、円形断面ガラス繊維を含む脂肪族ポリアミドの混合物中の半芳香族ポリアミドの使用 | 2024-02-19 |
19 | 特表2020-524139 | 骨髄増殖性腫瘍関連骨髄線維症及び貧血を治療するための方法 | 2024-02-16 |
20 | 特開2022-012576 | 水処理剤および水処理剤の安定化方法 | 2024-02-16 |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 1,242 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.4. The most inspection patent is 特許6529907 "マイコプラズマ・ニューモニエの免疫学的検出法およびキット" (16 times) , and the next most inspection patent is 特許6764792 "ケラチン処理調合物及び方法" (13 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6529907 | マイコプラズマ・ニューモニエの免疫学的検出法およびキット | 16 times |
2 | 特許6764792 | ケラチン処理調合物及び方法 | 13 times |
3 | 特許7462952 | 耐性澱粉およびその製造方法 | 13 times |
4 | 特開2020-109085 | ニコチン酸アミドを含有する油中水型乳化組成物 | 12 times |
5 | 特許7356228 | 組成物 | 11 times |
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 5,071 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.3. The most cited patent is 特許6475715 "ポリアミド組成物" (69 times) , and the next most cited patent is 特許6521977 "免疫調節剤としての1,2,4−オキサジアゾール誘導体" (39 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6475715 | ポリアミド組成物 | 69 times |
2 | 特許6521977 | 免疫調節剤としての1,2,4−オキサジアゾール誘導体 | 39 times |
3 | 特許6232009 | CDRのアミノ酸置換により抗体の等電点を改変する方法 | 37 times |
4 | 特許6196343 | 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド | 36 times |
5 | 特許6082447 | 複数分子の抗原に繰り返し結合する抗原結合分子 | 30 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International